Canalization is the way in which organisms develop phenotypic robustness as a response to genetic or environmental perturbations. This process ensures the stability of critical biological processes like blood glucose regulation. Canalization of this trait can be represented by a hyperbolic function of two underlying variables: insulin sensitivity and insulin response, as primarily described by Kahn et al. ([@B1],[@B2]).

Global migration in the early history of *Homo sapiens* placed people in new environments, resulting in novel diets, food scarcity, different climates, and exposure to novel pathogens. These changes may have shifted population averages of factors that influence insulin sensitivity and secretion. They include body size, body composition, energy expenditure, storage, and heat production. As these factors changed, they may have disclosed cryptic genetic variation or adopted novel mutations, leading to disruption of the unique point of stable equilibrium of ancestral populations. As this process continued over hundreds of millennia, specific genetic and environmental perturbations may have pushed some subpopulations to different points of stability ([@B1],[@B3]--[@B5]).

We hypothesized that there may be ethnic differences in the optimal states in the relationship between insulin sensitivity and insulin response and that these differences may depend on a population's genetic or evolutionary history. To assess this hypothesis, we performed a systematic review and a meta-analysis of studies of the insulin sensitivity index (*S*~I~) and the acute insulin response to glucose (AIR~g~). Our analysis was done in cohorts in any of the three major ethnic groups: Africans, Caucasians, and East Asians. We found significant differences between the groups.

RESEARCH DESIGN AND METHODS {#s1}
===========================

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used as a guidance for our meta-analytic study ([@B6]).

Literature search {#s2}
-----------------

We searched PubMed in October 2011 for articles measuring *S*~I~ and AIR~g~ with frequently sampled intravenous glucose tolerance tests (FSIGT) in Africans, Caucasians, or East Asians ([Supplementary Data](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)). Our keywords included ("acute insulin response" AND ("insulin sensitivity index" OR "Caucasian" OR "African" OR "Chinese" OR "Japanese" OR "Korean")) OR ("FSIGT" AND ("Caucasian" OR "African" OR "Chinese" OR "Japanese" OR "Korean")). In addition, we reviewed the reference lists of the articles we found to find more studies. The language of the studies was restricted to English.

Inclusion and exclusion criteria {#s3}
--------------------------------

A study article that met the following criteria was included: *1*) It determined individual *S*~I~ and AIR~g~ by FSIGT with minimal model (MINMOD) analysis ([@B7],[@B8]). *2*) It specified the measurement units of *S*~I~ and AIR~g~. *3*) It investigated a cohort composed of a single ethnicity. If there were multiple publications for the same study, we used the article with the most detailed information. We then classified the study cohorts into three groups: normal glucose tolerance (NGT), impaired glucose regulation (IGR), or type 2 diabetes (T2D). We used diagnoses made by the original authors; these diagnoses were based on recommendations of the World Health Organization, the American Diabetes Association, or the Japan Diabetes Society at the time of the study ([@B9]--[@B11]).

The NGT cohorts were further limited as follows. A cohort was included if it was composed of apparently healthy subjects (no evidence of systemic diseases influencing glycemic control). A cohort was excluded if it was composed of *1*) (mainly) obese subjects (mean of BMI \>30 kg/m^2^), *2*) subjects with a history of gestational diabetes mellitus, or *3*) subjects with a family history of T2D.

Data extraction {#s4}
---------------

Two investigators (K.K. and D.T.) independently reviewed the abstracts and the full text of all articles retrieved from PubMed. They made decisions about including or excluding them. Discrepancies in eligibility were discussed until agreement was achieved. Data were extracted independently by K.K. and D.T. Relevant data included the key author's name; year of publication; ethnicity of the population studied; number of participants; participants' mean age, BMI, and fasting glucose; and participants' mean ± SD *S*~I~ and AIR~g~. We converted different *S*~I~ units (e.g., ×10^−4^ ⋅ min^−1^/μU/mL) to the units used in Kahn's original study (×10^−5^ ⋅ min^−1^/pmol/L) ([@B2]). We also recalculated the values of AIR~g~ as the mean increment above basal level of insulin concentrations during the first peak and converted all units to those in Kahn's original study (pmol/L) ([@B2]). Differences in abstracted data were resolved by discussion and consensus with the other authors.

Data correction {#s5}
---------------

FSIGT with MINMOD analysis was conducted to evaluate *S*~I~ using one of the following three methods: no modification (regular), additional insulin administration at 20 min (insulin modified), or tolbutamide administration at 20 min (tolbutamide boosted). Two studies ([@B12],[@B13]) have reported that *S*~I~ measured by the insulin-modified protocol was systematically lower (16--29%) than that measured using tolbutamide, while another reported no significant difference between *S*~I\ (insulin)~ and *S*~I\ (regular)~ ([@B14]). Most of the studies in our meta-analysis used the insulin-modified or regular protocol ([Supplementary Table 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)**)**. The tolbutamide-boosted protocol was used in eight study cohorts for all of the participants (2 African and 6 Caucasian) and in four cohorts for the participants (1 African and 3 Caucasian) in the NGT category. It was used in two cohorts for all of the participants (2 Caucasian) in the IGR and for none in the T2D. To correct the effects of the tolbutamide studies, we converted their values of *S*~I\ (tolbutamide)~ to the approximate estimates of *S*~I\ (insulin)~ using the average rate of decline (25.9%) calculated from the data in the two references noted above ([@B12],[@B13]).

Quality assessment for individual studies and overall quality of evidence {#s6}
-------------------------------------------------------------------------

To evaluate quality and the risk of bias in each included study, we designed a scoring system for test results ([Supplementary Data](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)). Our system is a modification of the Newcastle-Ottawa Quality Assessment Scale, which was originally developed to assess the quality of nonrandomized studies ([@B44]). Our scale (the Modified Newcastle--Ottawa Quality Assessment Scale \[MNOS\]) awards a maximum of 9 points to each included study: up to 4 points for an adequate selection of a study population, up to 2 points for comparability of cohorts in the study \[i.e., absence of obvious confounding factor(s)\], and up to 3 points for the adequate measurement and presentation of study results. We defined studies as high quality if they scored the maximum 9 points on our scale; studies of medium quality scored 7--8 points, and studies that scored ≤6 points were defined as low quality.

We rated the overall quality of our evidence for each ethnic group by considering the quality (as measured by MNOS), the imprecision of results, or the possibility of publication bias according to recommendations by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Working Group ([@B15]).

Statistical analysis {#s7}
--------------------

The relationship between mean values of *S*~I~ and AIR~g~ across three ethnic groups was assessed using power (log-log) regression analysis. Additionally, we calculated combined mean values () and variances (*U~t~*) of *S*~I~ and AIR~g~ for all cohorts in each ethnic group (NGT, IGR, or T2D) as follows:

In this calculation, *k* was the number of cohorts in each ethnic group, *n~i~* was the sample size of cohort *i* in each ethnic group, *n~t~* was the total number of samples in each ethnic group, *X~i~* was the mean value of cohort *i* in each ethnic group, and *U~i~* was the variance of cohort *i* in each ethnic group. We made comparisons between multiple-group means with a Bonferroni corrected *t* test for pairwise group comparisons. A two-tailed *P* value \<0.017 (0.05/3) was considered to indicate statistical significance (3 comparisons). All analyzed data are represented as means ± SE unless otherwise noted.

RESULTS {#s8}
=======

Search results {#s9}
--------------

[Fig. 1](#F1){ref-type="fig"} is a flowchart showing how we identified study cohorts. Our PubMed search yielded 174 journal articles. After review of the full text and reference lists of each article, 48 studies including 94 cohorts met our selection criteria and were subjected to further screening. These cohorts were classified as NGT, IGR, and T2D, and the NGT group was further restricted according to our predetermined criteria. Eventually, we identified 74 ethnically homogeneous cohorts in which *S*~I~ and AIR~g~ were measured. There were 48 NGT (13 African, 23 Caucasian, and 12 East Asian), 15 IGR (3 African, 5 Caucasian, and 7 East Asian), and 11 T2D (3 African, 3 Caucasian, and 5 East Asian). They included 3,813 individuals ([Supplementary Table 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)).

![Flow diagram of literature search and cohort identification.](1789fig1){#F1}

Risk of bias assessment {#s10}
-----------------------

We used our MNOS scale to assess the quality of the individual studies for each ethnic group classified by degree of glucose tolerance. In NGT, 39 studies were deemed to be high quality (11 African, 19 Caucasian, and 9 East Asian), 8 were medium quality (2 African, 3 Caucasian, and 3 East Asian), and 1 was low quality (1 Caucasian; MNOS score: 5 points). Eleven IGR studies were of high quality (3 African, 3 Caucasian, and 5 East Asian), four were medium quality (2 Caucasian and 2 East Asian), and none were low quality. In T2D, eight studies were high quality (3 African, 1 Caucasian, and 4 East Asian), two were medium quality (1 Caucasian and 1 East Asian), and one was low quality (1 Caucasian; MNOS score: 6 points) ([Supplementary Table 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)). The studies defined as medium all lost points in the selection or comparability categories. The low-quality studies lost two points in a selection category and additional point(s) for other potential bias in either a comparability or an outcome category.

Ethnic differences in the relationship between *S*~I~ and AIR~g~ in NGT cohorts {#s11}
-------------------------------------------------------------------------------

We used the method of Kahn et al. ([@B2]) to calculate the hyperbolic relationship between insulin sensitivity and insulin response. We used mean values of *S*~I~ and AIR~g~ in the NGT (healthy) cohorts and then stratified distributions by ethnicity ([Fig. 2](#F2){ref-type="fig"}). Caucasian subpopulations clustered around the middle of the hyperbola, while African and East Asian subpopulations were located in unstable extreme points. In these areas, a small change in one variable is associated with a large nonlinear change in the other variable.

![Ethnic differences in the relationship between insulin sensitivity and insulin response in NGT cohorts. Scatter plot of *S*~I~ vs. AIR~g~ measured in NGT (healthy) African, Caucasian, and East Asian cohorts. Each circle represents one study cohort. Circle area is proportional to cohort sample size. The solid line is the curve calculated in our meta-analysis \[ln(AIR~g~) = --0.915 × ln(*S*~I~) -- 2.82\]. The dashed line is the curve of Kahn et al. ([@B2]) describing healthy individuals who were primarily Caucasian \[ln(AIR~g~) = --1.0 × ln(*S*~I~) -- 3.80\].](1789fig2){#F2}

We then compared the mean values of these parameters between the two different ethnic groups using a two-tailed Welch *t* test. We found that Africans had significantly lower insulin sensitivity (*S*~I~) and higher insulin response (AIR~g~) than the other two groups. Insulin sensitivity (*S*~I~) in East Asians was higher than the other two groups, while insulin response (AIR~g~) was much lower than that of Africans and lower than Caucasians \[*S*~I~ (×10^−5^ min^−1^/pmol/L), African 4.4 ± 0.14, Caucasian 7.1 ± 0.11, East Asian 11.9 ± 0.52, African vs. Caucasian *P* = 5.3 × 10^−5^, African vs. East Asian *P* = 1.9 × 10^−4^, and Caucasian vs. East Asian *P* = 0.002; AIR~g~ (pmol/L), African 997 ± 36.2, Caucasian 396 ± 7.5, East Asian 265 ± 13.7, African vs. Caucasian *P* = 6.4 × 10^−4^, African vs. East Asian *P* = 1.4 × 10^−4^, and Caucasian vs. East Asian *P* = 0.028\] ([Table 1](#T1){ref-type="table"}).

###### 

Characteristics of NGT, IGR, or T2D cohort subjects

![](1789tbl1)

Ethnic differences in the relationship between *S*~I~ and AIR~g~ across glucose tolerance subgroups {#s12}
---------------------------------------------------------------------------------------------------

Our findings raised the question of whether there was ethnic variation in the relationship between insulin sensitivity and insulin response across three glucose tolerance subgroups. To address this question, we plotted the mean and 95% CI values of *S*~I~ against AIR~g~ in subjects with NGT, IGR, and T2D from each ethnic group. We found ethnic variation in the distribution of *S*~I~ and AIR~g~ across the three glucose tolerance subgroups ([Table 1](#T1){ref-type="table"} and [Fig. 3](#F3){ref-type="fig"}). These results suggest that in Africans, insulin response may be strikingly reduced in the course from NGT to T2D via IGR. In the same groups of Caucasians, decreased insulin sensitivity could be more predominant than decreased insulin response. In East Asians, insulin sensitivity may be strikingly reduced, while insulin response was not changed in the course from NGT to IGR. However, insulin response could be rapidly reduced from IGR to T2D.

![Ethnic differences in the relationship between insulin sensitivity and insulin response across glucose tolerance subgroups. Plot of mean ± 95% CI values of *S*~I~ vs. AIR~g~ measured in NGT (circles), IGR (triangles), or T2D (squares) subjects across three ethnic cohorts.](1789fig3){#F3}

Publication bias {#s13}
----------------

We assessed the possibility of publication bias in our included studies for each ethnic group in NGT using the method of Macaskill, Walter, and Irwig ([@B16]). This method uses a funnel-plot regression of AIR~g~ or *S*~I~ on the sample size, weighted by the inverse variance. We found no evidence of publication bias (AIR~g~, African *P* = 0.18, Caucasian *P* = 0.78, and East Asian *P* = 0.24; *S*~I~, African *P* = 0.14, Caucasian *P* = 0.25, and East Asian *P* = 0.42 \[[Supplementary Fig. 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)\]). We did not examine possible publication bias of the results on IGR and T2D group, as guidelines do not recommend testing for funnel-plot asymmetry in analyses of \<10 studies ([@B17]).

Overall quality of evidence {#s14}
---------------------------

We assessed the overall quality of the evidence for each ethnic group classified by degree of glucose tolerance (NGT, IGR, or T2D), with reference to the GRADE system ([@B15]). In NGT, we considered our results for all of the three ethnic groups to be of high quality, as most studies in this category had received maximum MNOS points. In IGR, the results of Caucasians and East Asians were deemed to be of high quality, while results for Africans were of moderate quality. In T2D, we judged evidence for East Asians to be of high quality. It was of moderate quality for Africans and low quality for Caucasians. We graded the overall evidence quality for IGR and T2D Africans as moderate because there were only three studies (\<100 subjects) included in our meta-analysis. However, all of these studies had scored the maximum of 9 MNOS points. There were only three studies of T2D Caucasians (\<100 subjects) in our meta-analysis, and the quality scores for two were medium and low quality on the MNOS. Therefore, we graded the overall quality of evidence on the T2D Caucasians as low. Overall, we regarded our results on the differences in the relationship between *S*~I~ and AIR~g~ in NGT across three ethnic groups to be generalizable to other populations in the same ethnic groups. However, we think that the results on the IGR and T2D categories could be partially changed by further research because these categories included one or two ethnic groups rated as low or moderate quality of evidence.

CONCLUSIONS {#s15}
===========

We have confirmed that there is a hyperbolic relationship between insulin sensitivity and insulin response in African, Caucasian, and East Asian NGT cohorts. We discovered ethnic differences in the stabilization points of insulin sensitivity and insulin response to maintain the normal blood glucose levels (canalization).

It has been reported that average values of height, weight, BMI, body composition, and fat distribution differ by ethnic group. Among healthy subjects, Africans have less visceral fat area but more skeletal muscle and bone mineral mass than Caucasians, while Africans and Caucasians tend to have similar body sizes ([@B18]--[@B21]). East Asians have smaller mean height, weight, and BMI and less mean total visceral fat volume than Africans and Caucasians ([@B22]--[@B25]). In fact, the BMI cutoffs for normal weight, overweight, and obesity proposed for Japanese and Singaporean people (who are majority Chinese) are lower than international classification criteria. For example, the Japan Society for the Study of Obesity defines obese class 1 as BMI ≥25 kg/m^2^, whereas the International Obesity Task Force defines it as BMI ≥30 kg/m^2^ ([@B26]--[@B28]).

The AIR~g~ reflects pancreatic insulin secretion as well as hepatic insulin clearance. It is possible that lower AIR~g~ in healthy East Asians in our meta-analysis may be affected by either *1*) high insulin sensitivity due to low visceral fat content in healthy subjects or *2*) lower baseline function of insulin secretion or higher of insulin clearance sufficient to maintain smaller body size compared with the other two ethnic groups. Some researchers have reported that the relationship between insulin sensitivity and insulin responses might be linear rather than hyperbolic in the Japanese population ([@B29],[@B30]). It is possible that these research groups made this suggestion because they had observed only the part of the hyperbolic occupied by the Japanese population and misread it as a straight correlation line.

On the other hand, when we compared healthy Africans with healthy Caucasians, we found that the insulin response function was higher in Africans and that their insulin sensitivity was lower, as previously observed in many single studies ([@B31]--[@B33]). This finding was despite the fact that Africans have less visceral fat than Caucasians ([@B18]). It is paradoxical that Africans have less visceral fat and yet are more insulin resistant (and have greater insulin secretion and lesser insulin clearance) than other ethnic groups ([@B34],[@B35]). This finding contradicts the expected positive association between visceral fat and insulin resistance. However, it suggests that insulin resistance in healthy Africans may be influenced by other factors. It is possible that Africans' large amount of muscle and bone mass affects insulin sensitivity determinants, resulting in potential insulin resistance and more insulin response. In addition, a higher baseline insulin secretion or lower insulin clearance may be also needed to maintain and grow the large amount of muscle and bone in this group ([@B20],[@B21]).

In general, as obesity progresses and insulin sensitivity decreases, the insulin response increases to maintain NGT. This process can be seen as "moving up" the hyperbolic curve (canalization). β-Cell exhaustion can induce failure of this compensation cycle, resulting in a deviation from NGT that precipitates the development of IGR and T2D. This process can be seen as "falling off" the curve (decanalization) ([@B1],[@B36]).

We found that the stabilization points in the hyperbolic relationship between insulin sensitivity and insulin response in NGT Africans and East Asians are located around unstable extreme points in the curve in [Fig. 2](#F2){ref-type="fig"}. At these points, a small change in one variable is associated with a large nonlinear change in the other variable. This fact allows us to speculate that in Africans, even a small increase in insulin resistance in modern life could cause a rapid increase in the amount of insulin secretion required to maintain NGT. We assume that this unstable feedback loop may be implicated in this group's vulnerability of canalization of blood glucose levels. In fact, African Americans have a twofold higher risk of developing T2D compared with Caucasians ([@B37]).

It is thought that East Asians have a limited innate capacity of insulin secretion ([@B38]). This capacity may be decreased by aging or β-cell exhaustion due to continuous insulin resistance in many modern humans. We can therefore speculate that in East Asians, even a small decrease in insulin secretory function may lead to a rapid decrease in the threshold level of insulin resistance above which T2D occurs. This possible instability and vulnerability of canalization due to lower β-cell function may contribute to the increased prevalence of diabetes in East Asia in recent decades.

This systematic review and meta-analysis has strength and some limitations. An important strength of this work is that it is the first study to explicitly examine the relationship between insulin sensitivity and insulin response in three major ethnic groups, across different states of glucose tolerance, and on the basis of a comprehensive literature search. The major limitation in our meta-analysis is that we included only a few study cohorts (\<100 subjects) in some groups in the IGR and T2D categories (IGR Africans, T2D Africans, and T2D Caucasians), even if most of these studies included were rated as high quality in our MNOS scoring system. We acknowledge that the results concerning these groups may be slightly changed by further experiments.

Another limitation was that the definition of degrees of glucose tolerance was not precisely the same in all studies, primarily because the original authors used different criteria (World Health Organization, American Diabetes Association, or Japan Diabetes Society recommendations) ([@B9]--[@B11]). Additionally, we cannot exclude the possibility that some NGT cohorts may have included participants with either a family history of T2D or a history of gestational diabetes mellitus when the original authors did not indicate the exclusion criteria for those participants. These may have reduced the comparability of each group in our meta-analysis.

Further, there may be some points that could affect estimation of *S*~I~ values in Africans. For example, our criteria excluding obese cohorts from the NGT category may have inadvertently excluded insulin-sensitive individuals. There is evidence that overweight or obese insulin-sensitive subjects are predisposed to further weight gain ([@B39],[@B40]). We may have missed individuals with relatively high *S*~I~ and high AIR~g~ (predisposed to weight gain), especially in the African obese cohorts. Another potential issue is an artifact of the MINMOD analysis. This model was originally developed in dogs and was not intended to be used outside of a narrow range of insulin and glucose values ([@B7]). This range may be exceeded by the high AIR~g~ of NGT Africans. Several researchers have published studies concerning artifacts of MINMOD or the possibility of underestimation of *S*~I~ in the higher peak of insulin concentrations ([@B41]--[@B43]). We assume that the *S*~I~ values may have been underestimated in the individuals with high AIR~g~ in NGT Africans. These issues may have slightly shifted the combined data of *S*~I~ in NGT Africans in our meta-analysis.

Also, we acknowledge that most African subjects in our meta-analysis were unlikely to be of pure African ancestry, given that most of them were African Americans and may have some European ancestors. However, given the relative stability of Caucasian subjects here, this fact may mean that people of pure African descent could be even further up the hyperbolic curve than is indicated here.

Other factors that may have affected our results are related to methods used to evaluate *S*~I~. There were three methods: no modification (regular), insulin modified, or tolbutamide boosted. Two studies have reported that *S*~I\ (insulin)~ was systematically and significantly lower than *S*~I\ (tolbutamide)~ ([@B12],[@B13]), while another reported that *S*~I\ (insulin)~ was similar to *S*~I\ (regular)~ ([@B14]). Of the 74 study cohorts in our meta-analysis, 10 used a tolbutamide protocol for all participants in the cohorts and 4 for the part of participants. We adjusted errors that can occur owing to different measurement methods in the 12 studies according to previously reported data ([@B12],[@B13]). However, we could not correct the *S*~I~ values in the remaining two cohorts because the ratio of participant-administrated tolbutamide was not specified. This would have changed the results of the individual studies and, hence, slightly affected the results of combined data.

Finally, we acknowledge that our literature search may have missed studies involving FSIGT, AIR~g~, *S*~I~, and our three ethnic groups. PubMed searches only titles and abstracts and not the full text of articles. If the titles or abstracts of relevant studies did not include our keywords ([Supplementary Data](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1)), we would not have identified them for inclusion in our meta-analysis. Our search was also limited to publications in English, and we may have missed articles in other languages. For resolution of these limitations, we hope that a simultaneous multinational survey with a unified method and criteria will be conducted in the future.

In spite of these limitations, our results have significant implications for public health and clinical care. We have demonstrated that there is a hyperbolic relationship between insulin sensitivity and insulin response in healthy NGT cohorts across three ethnic groups (African, Caucasian, and East Asian). We also found an ethnically inherent difference in the optimal points in the canalization of normal blood glucose levels. In addition, we also found ethnic differences in the distribution of insulin sensitivity and insulin response in the course from NGT to T2D (decanalization). Our findings imply these scenarios: Africans have evolved to develop very robust β-cell function to maintain NGT despite having relatively higher insulin resistance. East Asians have evolved to be very insulin sensitive and thus require less robust β-cells. However, there are some Africans who cannot increase insulin secretion further, and they are prone to developing IGR and T2D with further decrease in insulin sensitivity. There are also some East Asians who, because they have especially vulnerable β-cells, despite relatively good insulin sensitivity, are unable to increase insulin secretion further if there is even a slight decrease in insulin sensitivity. These people thus develop IGR and T2D. In both scenarios, environmental factors that contribute to decreased insulin sensitivity would play roles in decanalization. Our findings suggest that it is necessary to consider a patient's ethnic background when addressing prevention, surveillance, and treatment of IGR and T2D.

This article contains Supplementary Data online at <http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1235/-/DC1>.
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